In patients with Type 1 Diabetes Mellitus (T1D) and T2D, the serum insulin concentration reaches its peak faster after inhalation of EXUBERA® (49 min, range = 30–90 min) than after subcutaneous injection of human regular insulin (105 min, range = 60–240 min) [12]. The gene discussed is INS; the disease is diabetes mellitus.